Nanette Santoro, MD

The compounded bioidentical hormone industry needs major changes in oversight to keep consumers safe.

Hormonal therapy is not without controversy but it is still one of the most effective treatments for patients with symptoms.

As patients are exposed to more and more misinformation, ob/gyns have a responsibility to not just treat but also educate.

GSM can be clinically detected in up to 90% of postmenopausal women undergoing evaluation but only one-third report vulvovaginal symptoms when surveyed.